BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
August 02, 2019 09:45 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Signs Exclusive Development Agreement With AstraZeneca
July 25, 2019 06:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery
June 12, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange
June 06, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class
May 23, 2019 15:23 ET
|
BioCardia, Inc.
PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
May 20, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported...
BioCardia Receives FDA Clearance for AVANCE Steerable Introducer for Transseptal Access to Heart
May 08, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...